Clinical Trial Update: CliniMACS® CD34+ Reagent System for Expanded Access Use

View source ↗

Summary

This clinical trial update states that expanded-access use of the CliniMACS CD34+ Reagent System is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Delayed Graft Function
• Graft Failure
• Graft-versus-host Disease

Drugs mentioned

• CliniMACS CD34+ Reagent System

Snippet

Sponsor: Joseph Antin | Conditions: Graft-Versus-Host Disease(GVHD), Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells | Status: NO_LONGER_AVAILABLE